10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
AMGEN INC | |||
Ticker: AMGN Fiscal Year: 2009 | |||
Statement Of Income Alternative | |||
Period Ending Dec 31, 2009 10-K (Filed: Mar 1, 2010) | |||
| (In Millions) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2009 | Dec 31, 2008 | Dec 31, 2007 | |
| Revenues: | |||
| Product sales | $ 14,351 | 14,687 | 14,311 |
| Other revenues | 291 | 316 | 460 |
| Total revenues | 14,642 | 15,003 | 14,771 |
| Operating expenses: | |||
| Cost of sales (excludes amortization of certain acquired intangible assets presented below) | 2,091 | 2,296 | 2,548 |
| Research and development | 2,864 | 3,030 | 3,266 |
| Selling, general and administrative | 3,820 | 3,789 | 3,361 |
| Amortization of certain acquired intangible assets | 294 | 294 | 298 |
| Write-off of acquired in-process research and development | 0 | 0 | 590 |
| Other charges | 67 | 380 | 728 |
| Total operating expenses | 9,136 | 9,789 | 10,791 |
| Operating income | 5,506 | 5,214 | 3,980 |
| Interest expense, net | 578 | 551 | 496 |
| Interest and other income, net | 276 | 352 | 309 |
| Income before income taxes | 5,204 | 5,015 | 3,793 |
| Provision for income taxes | 599 | 963 | 715 |
| Net income | 4,605 | 4,052 | 3,078 |
| Earnings per share: | |||
| Basic | 4.53 | 3.79 | 2.76 |
| Diluted | 4.51 | 3.77 | 2.74 |
| Shares used in calculation of earnings per share: | |||
| Basic | 1,016 | 1,070 | 1,117 |
| Diluted | 1,021 | 1,075 | 1,123 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
AMGEN INC | |||
Ticker: AMGN Fiscal Year: 2009 | |||
Statement Of Cash Flows Indirect | |||
Period Ending Dec 31, 2009 10-K (Filed: Mar 1, 2010) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2009 | Dec 31, 2008 | Dec 31, 2007 | |
| Cash flows from operating activities: | |||
| Net income | $ 4,605 | 4,052 | 3,078 |
| Depreciation and amortization | 1,049 | 1,073 | 1,202 |
| Write-off of acquired in-process research and development | 0 | 0 | 590 |
| Stock-based compensation expense | 284 | 262 | 263 |
| Deferred income taxes | 47 | (137) | 56 |
| Property, plant and equipment impairments | 21 | 59 | 404 |
| Dividend received from equity investee | 110 | 8 | 76 |
| Other items, net | 111 | 244 | 173 |
| Changes in operating assets and liabilities, net of acquisitions: | |||
| Trade receivables, net | (36) | 65 | 38 |
| Inventories | (134) | (59) | (109) |
| Other current assets | (3) | 15 | (119) |
| Accounts payable | 71 | 95 | (181) |
| Accrued income taxes | (142) | 14 | (810) |
| Other accrued liabilities | 320 | (30) | 688 |
| Deferred revenue | 33 | 327 | 52 |
| Net cash provided by operating activities | 6,336 | 5,988 | 5,401 |
| Cash flows from investing activities: | |||
| Purchases of property, plant and equipment | (530) | (672) | (1,267) |
| Cash paid for acquisitions, net of cash acquired | 0 | (56) | (697) |
| Purchases of marketable securities | (12,418) | (10,345) | (5,579) |
| Proceeds from sales of marketable securities | 8,252 | 6,762 | 5,073 |
| Proceeds from maturities of marketable securities | 1,443 | 1,018 | 454 |
| Other | 51 | 128 | 24 |
| Net cash used in investing activities | (3,202) | (3,165) | (1,992) |
| Cash flows from financing activities: | |||
| Repurchases of common stock | (3,208) | (2,268) | (5,100) |
| Repayment of debt | (1,000) | (2,000) | (1,840) |
| Net proceeds from issuance of debt | 1,980 | 991 | 3,982 |
| Net proceeds from issuance of common stock in connection with the Company's equity award programs | 171 | 155 | 277 |
| Other | 33 | 49 | 13 |
| Net cash used in financing activities | (2,024) | (3,073) | (2,668) |
| Increase (decrease) in cash and cash equivalents | 1,110 | (250) | 741 |
| Cash and cash equivalents at beginning of period | 1,774 | 2,024 | |
| Cash and cash equivalents at end of period | 2,884 | 1,774 | 2,024 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||
AMGEN INC | ||
Ticker: AMGN Fiscal Year: 2009 | ||
Statement Of Financial Position Classified | ||
Period Ending Dec 31, 2009 10-K (Filed: Mar 1, 2010) | ||
| (In Millions, except shares in actual) | ||
| As of | As of | |
| Dec 31, 2009 | Dec 31, 2008 | |
| ASSETS | ||
| Current assets: | ||
| Cash and cash equivalents | $ 2,884 | 1,774 |
| Marketable securities | 10,558 | 7,778 |
| Trade receivables, net | 2,109 | 2,073 |
| Inventories | 2,220 | 2,075 |
| Other current assets | 1,161 | 1,521 |
| Total current assets | 18,932 | 15,221 |
| Property, plant and equipment, net | 5,738 | 5,879 |
| Intangible assets, net | 2,567 | 2,988 |
| Goodwill | 11,335 | 11,339 |
| Other assets | 1,057 | 1,000 |
| Total assets | 39,629 | 36,427 |
| LIABILITIES AND STOCKHOLDERS' EQUITY | ||
| Current liabilities: | ||
| Accounts payable | 574 | 504 |
| Accrued liabilities | 3,299 | 3,382 |
| Current portion of other long-term debt | 0 | 1,000 |
| Total current liabilities | 3,873 | 4,886 |
| Convertible notes | 4,512 | 4,257 |
| Other long-term debt | 6,089 | 4,095 |
| Other non-current liabilities | 2,488 | 2,304 |
| Contingencies and commitments | ||
| Stockholders' equity: | ||
| Common stock and additional paid-in capital; $0.0001 par value; 2,750 shares authorized; outstanding - 995 shares in 2009 and 1,047 shares in 2008 | 26,944 | 26,441 |
| Accumulated deficit | (4,322) | (5,673) |
| Accumulated other comprehensive income | 45 | 117 |
| Total stockholders' equity | 22,667 | 20,885 |
| Total liabilities and stockholders' equity | 39,629 | 36,427 |
| External Links | |
| AMGEN INC (AMGN) Fiscal Year 2009 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |